Violation Tracker Parent Company Summary

Parent Company Name: 
Sanofi
Ownership Structure: 
publicly traded
Headquartered in: 
France
Major Industry: 
pharmaceuticals
Specific Industry: 
pharmaceuticals
Penalty total since 2000: 
$544,996,233
Number of records: 
11
Top 10 Primary Offense TypesPenalty TotalNumber of Records
False Claims Act$436,648,1945
drug or medical equipment safety violation$55,781,0392
Foreign Corrupt Practices Act$25,200,0001
employment discrimination$15,360,0001
price-fixing or anti-competitive practices$12,000,0001
workplace safety or health violation$7,0001
Notes: 

Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty dollar total above may be adjusted to account for the fact that the list of entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. Duplicate penalty amounts are marked with an asterisk in the list below.

Associated Names: 

AVENTIS PHARMACEUTICAL; AVENTIS PHARMACEUTICALS; GENZYME; Hoechst AG; ROUSSEL UCLAF SA; SANOFI; Sanofi-Aventis U.S. LLC

Links: 

For more details on misconduct by this company, see its entry in the Project On Government Oversight's Federal Contractor Misconduct Database.

For a summary of this company's federal contracts, see its page on Fedspending.

Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.


Individual Penalty Records:

Click on the company or penalty amount for more information on each case.
Download results as CSV or XML
Company Primary Offense Type Year Agency Penalty Amountsort icon
Aventis Pharmaceuticals Inc. False Claims Act 2007 DOJ_CIVIL $190,000,000
Sanofi-Aventis U.S. Inc. False Claims Act 2012 DOJ_CIVIL $109,000,000
Aventis Pharmaceutical Inc. False Claims Act 2009 DOJ_CIVIL $95,500,000
Genzyme Corporation drug or medical equipment safety violation 2015 FDA $32,587,439
Sanofi Foreign Corrupt Practices Act 2018 SEC $25,200,000
Roussel Uclaf S.A. drug or medical equipment safety violation 2001 USAO $23,193,600
Genzyme Corp. False Claims Act 2013 DOJ_CIVIL $22,280,000
Sanofi-Pasteur False Claims Act 2017 DOJ_CIVIL $19,868,194
Sanofi-Aventis U.S. LLC employment discrimination 2010 private lawsuit-federal $15,360,000
Hoechst AG price-fixing or anti-competitive practices 2003 DOJ_ANTITRUST $12,000,000
SANOFI PASTEUR INC. workplace safety or health violation 2014 OSHA $7,000
Download results as CSV or XML